Skip to content

A Multicenter Clinical Randomized Controlled Double-Blind Study of Accelerated Mode of Sustained Bursts (cTBS) for the Treatment of Depression

A Multicenter Clinical Randomized Controlled Double-Blind Study of Accelerated Mode of Sustained Bursts (cTBS) for the Treatment of Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085480
Enrollment
Unknown
Registered
2024-06-07
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

A-cTBS group:Accelerated cTBS intervention
Sham a-cTBS group:Sham a-cTBS intervention

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Be 18 to 65 years of age; 2) Diagnosis of depression in accordance with the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) or ICD-10; 3) A total HAMD-17 score of >=17; 4) Right-handedness; 5) The patient's physical examination, medical history, vital signs, blood, urine and stool routine, liver and kidney function, electrolytes, electrocardiogram, electroencephalogram and other indicators are normal; 6) After fully understanding the safety of transcranial magnetic stimulation (TMS), they are willing to actively cooperate with the treatment and sign informed consent by themselves and their families.

Exclusion criteria

Exclusion criteria: 1) Those with a history of severe physical illness and depression due to other psychoactive and non-dependent substances; 2) Patients with metallic or electronic instruments placed in the body, such as intracranial metallic foreign bodies, cochlear implants, pacemakers and stents, and other metallic foreign bodies; 3) Those at risk for seizures, with previous cranial disease, head trauma, alcoholism, EEG abnormalities, MRI evidence of structural abnormalities in the brain, or a family history of epilepsy; 4) Those with psychotic symptoms requiring a combination of should antipsychotic medications; 5) Receiving other physical therapy after enrollment; 6) Those who are pregnant, breastfeeding, or planning to become pregnant during the trial; 7) Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Clinical Scale Assessment;

Secondary

MeasureTime frame
Electromyographic changes;EEG changes;Near infrared functional imaging;Imaging indicators;Behavioral;

Countries

China

Contacts

Public ContactDongsheng Zhou

Affiliated Kangning Hospital of Ningbo University

wyzhouds@sina.com+86 574 26302565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026